Sands Capital Ventures as of Sept. 30, 2022
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 18 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dice Therapeutics | 18.6 | $64M | 3.1M | 20.28 | |
| Uipath Com Cl A (PATH) | 14.0 | $48M | 3.8M | 12.61 | |
| Nu Holdings Com Cl A (NU) | 11.7 | $40M | 9.1M | 4.40 | |
| Snowflake Com Cl A (SNOW) | 10.6 | $37M | 215k | 169.96 | |
| Acumen Pharmaceuticals (ABOS) | 10.0 | $34M | 3.4M | 10.03 | |
| Samsara Com Cl B | 9.5 | $33M | 2.7M | 12.07 | |
| Doordash Com Cl A (DASH) | 8.6 | $30M | 602k | 49.45 | |
| 10X Genomics Com Cl A (TXG) | 4.0 | $14M | 482k | 28.48 | |
| Karuna Therapeutics Ord | 3.9 | $13M | 59k | 224.93 | |
| Olink Hldg Ab (OLK) | 2.5 | $8.6M | 706k | 12.14 | |
| 908 Devices (MASS) | 1.6 | $5.4M | 326k | 16.45 | |
| Tarsus Pharmaceuticals (TARS) | 1.3 | $4.5M | 260k | 17.12 | |
| Repligen Corporation (RGEN) | 1.2 | $4.2M | 23k | 187.10 | |
| Samsara Com Cl A (IOT) | 1.1 | $3.9M | 326k | 12.07 | |
| Candel Therapeutics (CADL) | 0.7 | $2.5M | 812k | 3.14 | |
| Taysha Gene Therapies (TSHA) | 0.4 | $1.4M | 725k | 1.93 | |
| Spruce Biosciences (SPRB) | 0.3 | $1.1M | 787k | 1.37 | |
| Absci Corp (ABSI) | 0.1 | $181k | 58k | 3.13 |
